Physician profile
Amber Wells
NPI 1588230411
$946.99
in general payments reported to CMS, 2019-2025
20 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $222 · 2023: $333 · 2024: $124 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $606.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $276.14 | 2021-2024 | |
| Madrigal Pharmaceuticals | $149.06 | 2025 | Rezdiffra |
| Ucb, INC. | $57.49 | 2021-2023 | Briviact |
| Tanabe Pharma America, INC. | $45.14 | 2023-2024 | |
| Amgen INC. | $44.61 | 2022-2023 | Prolia, Evenity |
| Lundbeck LLC | $42.50 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $39.18 | 2022 | |
| Kci USA, INC. | $37.27 | 2023 | Prevena, V.A.C. Dermatac |
| Eisai INC. | $34.68 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $27.90 | 2022 | |
| Radius Health, INC. | $22.53 | 2022 | |
| Bioventus LLC | $22.12 | 2023 | Bonescalpel |
| Banner Life Sciences, LLC | $21.86 | 2023 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $21.57 | 2022 | |
| Grifols USA, LLC | $20.63 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $19.67 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $19.12 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $19.09 | 2021 | |
| Avion Pharmaceuticals | $14.05 | 2023 | Dhivy |
| Teva Pharmaceuticals USA, INC. | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.